Overview
Thiemann disease (also known as Thiemann epiphyseal disease or familial avascular necrosis of the phalangeal epiphyses) is a rare inherited skeletal disorder characterized by avascular necrosis (loss of blood supply leading to bone death) of the epiphyses (growth plates) of the phalangeal bones of the hands and, less commonly, the feet. The condition primarily affects the proximal interphalangeal joints of the fingers, leading to progressive joint swelling, stiffness, pain, and eventual deformity. Onset typically occurs during childhood or adolescence, often becoming apparent during periods of active growth. The fingers may develop a characteristic fusiform (spindle-shaped) swelling, and radiographic imaging reveals irregularity, fragmentation, and flattening of the affected epiphyses. The familial form of Thiemann disease follows an autosomal dominant inheritance pattern, meaning that a single copy of the altered gene from one affected parent is sufficient to cause the condition. Some cases have been linked to mutations in genes involved in cartilage and bone development, though the precise genetic basis is not fully established in all families. The disease predominantly affects the musculoskeletal system, and the degree of functional impairment can vary considerably among affected individuals, ranging from mild joint stiffness to significant limitation of hand function. There is currently no specific cure or disease-modifying treatment for Thiemann disease. Management is primarily supportive and symptomatic, focusing on pain relief through analgesics and anti-inflammatory medications, physical therapy to maintain joint mobility, and occupational therapy to preserve hand function. In severe cases with significant joint deformity or functional impairment, surgical intervention may be considered. The prognosis is generally favorable, as the disease tends to stabilize after skeletal maturity is reached, though residual joint deformity and some degree of functional limitation may persist.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Juvenile
Begins in the teen years
Treatments
No FDA-approved treatments are currently listed for Thiemann disease, familial form.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Thiemann disease, familial form at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Thiemann disease, familial form.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Thiemann disease, familial form.
Community
No community posts yet. Be the first to share your experience with Thiemann disease, familial form.
Start the conversation →Latest news about Thiemann disease, familial form
No recent news articles for Thiemann disease, familial form.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Thiemann disease, familial form
What is Thiemann disease, familial form?
Thiemann disease (also known as Thiemann epiphyseal disease or familial avascular necrosis of the phalangeal epiphyses) is a rare inherited skeletal disorder characterized by avascular necrosis (loss of blood supply leading to bone death) of the epiphyses (growth plates) of the phalangeal bones of the hands and, less commonly, the feet. The condition primarily affects the proximal interphalangeal joints of the fingers, leading to progressive joint swelling, stiffness, pain, and eventual deformity. Onset typically occurs during childhood or adolescence, often becoming apparent during periods of
How is Thiemann disease, familial form inherited?
Thiemann disease, familial form follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Thiemann disease, familial form typically begin?
Typical onset of Thiemann disease, familial form is juvenile. Age of onset can vary across affected individuals.